President Donald Trump has repeatedly assured U.S. citizens that his administration would secure enough COVID-19 vaccine doses to protect the nation. However, a new report shows his government failed to act in securing additional doses of Pfizer and BioNTech’s vaccine this summer.
On Monday, The New York Times reported the Trump administration passed on the opportunity to acquire additional doses of the COVID-19 vaccine frontrunner beyond the 100 million doses the government purchased in July’s $1.95 billion deal. Given that the Pfizer and BioNTech vaccine is a two-dose treatment, that means about 50 million Americans will initially receive the vaccine.
